Boston Scientific approves 2026 annual bonus and performance share programs with similar structure to 2025

BOSTON SCIENTIFIC CORP

2026 Annual Bonus Plan approved; bonus pool 0%-150% of target based on global sales, adjusted EPS, operating income, and sustainability goals.
2026 rTSR PSP measures TSR vs S&P 500 Healthcare Index over 3 years (2026-2028); awards 0%-200% of target.
2026 Organic Net Sales PSP measures organic net sales growth vs financial plan over 3 years; awards 0%-200% of target.
Both performance programs forfeit if retirement before Jan 1, 2027; all awards subject to clawback policies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.